Skip to main navigation Skip to search Skip to main content

Efficacy, and safety of remdesivir in people with moderately and severely reduced kidney function hospitalized for COVID-19: The REDPINE study

Research output: Other contribution

Abstract

Accepted to ECCMID 2023

Original languageUndefined/Unknown
StatePublished - Feb 1 2023

Publication series

NameArticles, Abstracts, and Reports

Cite this